NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age

Expert Review of Neurotherapeutics - Tập 14 Số 11 - Trang 1293-1306 - 2014
G. Kenneth Gray1, Braden C. McFarland1, Susan E. Nozell1, Etty Benveniste
1Department of Cell, Developmental and Integrative Biology, 1900 University Blvd, THT 926A, University of Alabama at Birmingham, Birmingham, AL, 35294-0006, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Porter KR, 2010, Neuro Oncol, 12, 520, 10.1093/neuonc/nop066

10.1093/neuonc/nos218

Stupp R, 2005, N Engl J Med, 352, 987, 10.1056/NEJMoa043330

10.1056/NEJMra0708126

Omuro A, 2013, JAMA, 310, 1842, 10.1001/jama.2013.280319

10.1056/NEJMoa1308345

10.1056/NEJMoa1308573

10.1200/JCO.2009.26.3541

Ng K, 2012, J Neurooncol, 107, 1, 10.1007/s11060-011-0714-2

10.1016/S1470-2045(06)70665-9

Westphal M, 2011, Nat Rev Neurosci, 12, 495, 10.1038/nrn3060

10.3322/caac.20069

Fisher JL, 2007, Neurol Clin, 25, 867, 10.1016/j.ncl.2007.07.002

10.1056/NEJMoa065901

Roa W, 2004, J Clin Oncol, 22, 1583, 10.1200/JCO.2004.06.082

Glantz M, 2003, Cancer, 97, 2262, 10.1002/cncr.11323

10.1016/j.ccr.2009.12.020

10.1016/j.ccr.2010.03.017

Turcan S, 2012, Nature, 483, 479, 10.1038/nature10866

Brennan CW, 2013, Cell, 155, 462, 10.1016/j.cell.2013.09.034

10.1016/j.ccr.2006.02.019

Carro MS, 2010, Nature, 463, 318, 10.1038/nature08712

10.1073/pnas.1219747110

10.1126/science.1254257

Basseres DS, 2006, Oncogene, 25, 6817, 10.1038/sj.onc.1209942

Hoffmann A, 2006, Immunol Rev, 210, 171, 10.1111/j.0105-2896.2006.00375.x

Karin M, 2006, Mol Carcinog, 45, 355, 10.1002/mc.20217

Perkins ND, 2012, Nat Rev Cancer, 12, 121, 10.1038/nrc3204

Bhat KP, 2013, Cancer Cell, 24, 331, 10.1016/j.ccr.2013.08.001

Karlebach G, 2010, BMC Syst Biol, 4, 15, 10.1186/1752-0509-4-15

Grivennikov SI, 2011, Ann Rheum Dis, 70, i104, 10.1136/ard.2010.140145

Hayashi S, 2001, Neurol Med Chir (Tokyo), 41, 187, 10.2176/nmc.41.187

10.1007/s11060-005-9097-6

Huang P, 2012, Cancer Res, 72, 1428, 10.1158/0008-5472.CAN-11-2621

10.18632/oncotarget.322

Puliyappadamba VT, 2013, Cell Rep, 4, 764, 10.1016/j.celrep.2013.07.025

Bonavia R, 2012, Oncogene, 31, 4054, 10.1038/onc.2011.563

Yang W, 2012, Mol Cell, 48, 771, 10.1016/j.molcel.2012.09.028

Tanaka K, 2011, Cancer Discov, 1, 524, 10.1158/2159-8290.CD-11-0124

Atkinson GP, 2010, Expert Rev Neurother, 10, 575, 10.1586/ern.10.21

Holmes KM, 2012, Proc Natl Acad Sci USA, 109, 3475, 10.1073/pnas.1120375109

Nozell S, 2008, Mol Cell Biol, 28, 6632, 10.1128/MCB.00697-08

10.1038/onc.2009.232

Zhang T, 2013, Nat Commun, 4, 2062, 10.1038/ncomms3062

10.1056/NEJMoa1006312

Patane M, 2013, Mol Cancer, 12, 160, 10.1186/1476-4598-12-160

Nogueira L, 2011, Oncogene, 30, 3537, 10.1038/onc.2011.74

Hjelmeland AB, 2010, PLoS Biol, 8, e1000319, 10.1371/journal.pbio.1000319

Hummel R, 2011, Mol Neurobiol, 44, 223, 10.1007/s12035-011-8197-x

Ciafre SA, 2005, Biochem Biophys Res Commun, 334, 1351, 10.1016/j.bbrc.2005.07.030

10.1158/0008-5472.CAN-08-1305

Chen Y, 2008, Cancer Lett, 272, 197, 10.1016/j.canlet.2008.06.034

Chan JA, 2005, Cancer Res, 65, 6029, 10.1158/0008-5472.CAN-05-0137

Lakomy R, 2011, Cancer Sci, 102, 2186, 10.1111/j.1349-7006.2011.02092.x

Li Y, 2009, Brain Res, 1286, 13, 10.1016/j.brainres.2009.06.053

Song L, 2012, J Clin Invest, 122, 3563, 10.1172/JCI62339

Jiang L, 2012, J Clin Invest, 122, 33, 10.1172/JCI58849

Wang S, 2014, J Neurol Sci, 338, 71, 10.1016/j.jns.2013.12.019

Hua D, 2012, Oncol Rep, 27, 700

10.1371/journal.pone.0017438

Yang G, 2014, Neuro Oncol, 16, 652, 10.1093/neuonc/not307

10.1038/cr.2012.174

Xia H, 2013, Neuro Oncol, 15, 413, 10.1093/neuonc/nos296

Yin D, 2005, Oncogene, 24, 344, 10.1038/sj.onc.1208225

10.1007/s11060-010-0143-7

Coupienne I, 2011, Biochem Pharmacol, 81, 606, 10.1016/j.bcp.2010.12.015

Shukla S, 2013, Cancer Res, 73, 6563, 10.1158/0008-5472.CAN-13-0298

Fukushima T, 2012, Neuro Oncol, 14, 19, 10.1093/neuonc/nor168

Brassesco MS, 2013, Chemother Res Pract, 2013, 593020

McFarland BC, 2013, PLoS One, 8, e78728, 10.1371/journal.pone.0078728

10.1016/j.immuni.2012.03.013

10.1038/nrc2734

Wagner KU, 2011, J Carcinog, 10, 32, 10.4103/1477-3163.90677

Decker T, 2000, Oncogene, 19, 2628, 10.1038/sj.onc.1203481

Aziz MH, 2010, Oncogene, 29, 3100, 10.1038/onc.2010.63

Xu Y, 2014, J Mol Neurosci

Kim E, 2013, Cancer Cell, 23, 839, 10.1016/j.ccr.2013.04.008

Brantley EC, 2008, Clin Cancer Res, 14, 4694, 10.1158/1078-0432.CCR-08-0618

Lee K, 2013, Genome Res, 23, 1283, 10.1101/gr.155499.113

10.1158/1541-7786.MCR-07-2180

Lin GS, 2014, Med Oncol, 31, 924, 10.1007/s12032-014-0924-5

Halliday J, 2014, Proc Natl Acad Sci USA, 111, 5248, 10.1073/pnas.1321014111

10.1158/0008-5472.CAN-10-4117

Cui X, 2014, Cancer Sci, 105, 64, 10.1111/cas.12313

Wang H, 2009, Stem Cells, 27, 2393, 10.1002/stem.188

Cao Y, 2010, Genes Cancer, 1, 50, 10.1177/1947601909356352

Doucette TA, 2012, Neuro Oncol, 14, 1136, 10.1093/neuonc/nos139

Kim Y, 2012, Genes Dev, 26, 1247, 10.1101/gad.193565.112

Fan QW, 2013, Cancer Cell, 24, 438, 10.1016/j.ccr.2013.09.004

Garnett J, 2013, Neoplasia, 15, 73, 10.1593/neo.121536

Zhou M, 2013, Cancer Res, 73, 7056, 10.1158/0008-5472.CAN-13-0194

10.1038/ng.2734

10.1158/0008-5472.CAN-12-4318

10.1016/j.cell.2011.09.041

Veeriah S, 2009, Proc Natl Acad Sci USA, 106, 9435, 10.1073/pnas.0900571106

Ortiz B, 2014, Proc Natl Acad Sci USA, 111, 8149, 10.1073/pnas.1401952111

Nilsson CL, 2010, J Proteome Res, 9, 430, 10.1021/pr9007927

da Fonseca AC, 2013, Clin Dev Immunol, 2013, 264124

Wu A, 2010, Neuro Oncol, 12, 1113, 10.1093/neuonc/noq082

Wei J, 2010, Mol Cancer Ther, 9, 67, 10.1158/1535-7163.MCT-09-0734

10.1371/journal.pone.0016195

McFarland BC, 2011, Mol Cancer Ther, 10, 2384, 10.1158/1535-7163.MCT-11-0480

Zheng Q, 2014, Neuro Oncol, 16, 1229, 10.1093/neuonc/nou046

He K, 2013, Sci Signal, 6, ra55

Ball S, 2011, PLoS One, 6, e18820, 10.1371/journal.pone.0018820

Kohsaka S, 2012, Mol Cancer Ther, 11, 1289, 10.1158/1535-7163.MCT-11-0801

de Groot J, 2012, Oncotarget, 3, 1036, 10.18632/oncotarget.663

10.1016/j.ccr.2009.01.027

10.1016/j.ccr.2012.05.037

Lu KV, 2013, CNS Oncol, 2, 49, 10.2217/cns.12.36

Grivennikov SI, 2010, Cell, 140, 883, 10.1016/j.cell.2010.01.025

Fan Y, 2013, Protein Cell, 4, 176, 10.1007/s13238-013-2084-3

Kesanakurti D, 2013, Oncogene, 32, 5144, 10.1038/onc.2012.546

Iliopoulos D, 2009, Cell, 139, 693, 10.1016/j.cell.2009.10.014

Iliopoulos D, 2010, Mol Cell, 39, 493, 10.1016/j.molcel.2010.07.023

Lee H, 2009, Cancer Cell, 15, 283, 10.1016/j.ccr.2009.02.015

Xiang M, 2014, Sci Signal, 7, ra11, 10.1126/scisignal.2004497

Rokavec M, 2012, Mol Cell, 45, 777, 10.1016/j.molcel.2012.01.015

Dominguez I, 2009, Cell Mol Life Sci, 66, 1850, 10.1007/s00018-009-9153-z

Zheng Y, 2011, Blood, 118, 156, 10.1182/blood-2010-01-266320

Zheng Y, 2013, Clin Cancer Res, 19, 6484, 10.1158/1078-0432.CCR-13-0265

10.1038/sj.onc.1210031

10.1158/0008-5472.CAN-07-1243

Kong LY, 2010, Clin Cancer Res, 16, 5722, 10.1158/1078-0432.CCR-10-1693

Weissenberger J, 2010, Clin Cancer Res, 16, 5781, 10.1158/1078-0432.CCR-10-0446

Senft C, 2010, BMC Cancer, 10, 491, 10.1186/1471-2407-10-491

Juttler E, 2004, Neuropharmacology, 47, 580, 10.1016/j.neuropharm.2004.05.009

Kumar AP, 2003, Carcinogenesis, 24, 209, 10.1093/carcin/24.2.209

Muh CR, 2014, J Neurooncol, 116, 89, 10.1007/s11060-013-1283-3

Jackson CM, 2014, Clin Cancer Res, 20, 3651, 10.1158/1078-0432.CCR-13-2057

Leder K, 2014, Cell, 156, 603, 10.1016/j.cell.2013.12.029